OXBDF
Price
$5.17
Change
+$0.07 (+1.37%)
Updated
Jul 22 closing price
Capitalization
557.03M
PRRUF
Price
$0.19
Change
-$0.02 (-9.52%)
Updated
May 29 closing price
Capitalization
249.78M
Interact to see
Advertisement

OXBDF vs PRRUF

Header iconOXBDF vs PRRUF Comparison
Open Charts OXBDF vs PRRUFBanner chart's image
Oxford Biomedica
Price$5.17
Change+$0.07 (+1.37%)
Volume$156
Capitalization557.03M
Immutep
Price$0.19
Change-$0.02 (-9.52%)
Volume$600
Capitalization249.78M
OXBDF vs PRRUF Comparison Chart in %
Loading...
OXBDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRRUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OXBDF vs. PRRUF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OXBDF is a Buy and PRRUF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (OXBDF: $5.17 vs. PRRUF: $0.19)
Brand notoriety: OXBDF and PRRUF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OXBDF: 13% vs. PRRUF: 95%
Market capitalization -- OXBDF: $557.03M vs. PRRUF: $249.78M
OXBDF [@Biotechnology] is valued at $557.03M. PRRUF’s [@Biotechnology] market capitalization is $249.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OXBDF’s FA Score shows that 0 FA rating(s) are green whilePRRUF’s FA Score has 0 green FA rating(s).

  • OXBDF’s FA Score: 0 green, 5 red.
  • PRRUF’s FA Score: 0 green, 5 red.
According to our system of comparison, OXBDF is a better buy in the long-term than PRRUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OXBDF’s TA Score shows that 4 TA indicator(s) are bullish while PRRUF’s TA Score has 1 bullish TA indicator(s).

  • OXBDF’s TA Score: 4 bullish, 3 bearish.
  • PRRUF’s TA Score: 1 bullish, 1 bearish.
According to our system of comparison, OXBDF is a better buy in the short-term than PRRUF.

Price Growth

OXBDF (@Biotechnology) experienced а +3.40% price change this week, while PRRUF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OXBDF($557M) has a higher market cap than PRRUF($250M). OXBDF YTD gains are higher at: -4.171 vs. PRRUF (-4.879).
OXBDFPRRUFOXBDF / PRRUF
Capitalization557M250M223%
EBITDAN/A-43.83M-
Gain YTD-4.171-4.87985%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A159M-
Total DebtN/A1.69M-
FUNDAMENTALS RATINGS
OXBDF vs PRRUF: Fundamental Ratings
OXBDF
PRRUF
OUTLOOK RATING
1..100
4137
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
10083
SMR RATING
1..100
9396
PRICE GROWTH RATING
1..100
4259
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OXBDF's Valuation (69) in the null industry is in the same range as PRRUF (85). This means that OXBDF’s stock grew similarly to PRRUF’s over the last 12 months.

PRRUF's Profit vs Risk Rating (83) in the null industry is in the same range as OXBDF (100). This means that PRRUF’s stock grew similarly to OXBDF’s over the last 12 months.

OXBDF's SMR Rating (93) in the null industry is in the same range as PRRUF (96). This means that OXBDF’s stock grew similarly to PRRUF’s over the last 12 months.

OXBDF's Price Growth Rating (42) in the null industry is in the same range as PRRUF (59). This means that OXBDF’s stock grew similarly to PRRUF’s over the last 12 months.

OXBDF's P/E Growth Rating (98) in the null industry is in the same range as PRRUF (100). This means that OXBDF’s stock grew similarly to PRRUF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OXBDFPRRUF
RSI
ODDS (%)
Bearish Trend 2 days ago
45%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
53%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
57%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 3 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 5 days ago
66%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
57%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
46%
View a ticker or compare two or three
Interact to see
Advertisement
OXBDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRRUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FASIX14.03N/A
N/A
Fidelity Asset Manager 20%
CSMCX47.69N/A
N/A
Congress Small Cap Growth Institutional
PDFDX46.03N/A
N/A
Perkins Discovery
PGUCX15.78N/A
N/A
Virtus Duff & Phelps Global Infras C
PRPCX4.89N/A
N/A
PGIM Jennison Energy Infrastructure C

OXBDF and

Correlation & Price change

A.I.dvisor tells us that OXBDF and IMMP have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OXBDF and IMMP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OXBDF
1D Price
Change %
OXBDF100%
N/A
IMMP - OXBDF
23%
Poorly correlated
+1.18%
BPMC - OXBDF
21%
Poorly correlated
N/A
BDTX - OXBDF
21%
Poorly correlated
-4.81%
ATNM - OXBDF
21%
Poorly correlated
-1.65%
PRRUF - OXBDF
9%
Poorly correlated
N/A
More

PRRUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRRUF has been loosely correlated with IMMP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PRRUF jumps, then IMMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRRUF
1D Price
Change %
PRRUF100%
N/A
IMMP - PRRUF
43%
Loosely correlated
+1.18%
CALC - PRRUF
24%
Poorly correlated
+2.98%
PHGUF - PRRUF
21%
Poorly correlated
N/A
PVCT - PRRUF
11%
Poorly correlated
+3.45%
OXBDF - PRRUF
9%
Poorly correlated
N/A
More